These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 27688189)

  • 21. [18F]DPA-714, [18F]PBR111 and [18F]FEDAA1106-selective radioligands for imaging TSPO 18 kDa with PET: automated radiosynthesis on a TRACERLAb FX-FN synthesizer and quality controls.
    Kuhnast B; Damont A; Hinnen F; Catarina T; Demphel S; Le Helleix S; Coulon C; Goutal S; Gervais P; Dollé F
    Appl Radiat Isot; 2012 Mar; 70(3):489-97. PubMed ID: 22104496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and structure-activity relationships of 5,6,7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging.
    Tang D; McKinley ET; Hight MR; Uddin MI; Harp JM; Fu A; Nickels ML; Buck JR; Manning HC
    J Med Chem; 2013 Apr; 56(8):3429-33. PubMed ID: 23521048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of PET Imaging Performance of the TSPO Radioligand [18F]DPA-714 in Mouse and Rat Models of Cancer and Inflammation.
    Zheng J; Winkeler A; Peyronneau MA; Dollé F; Boisgard R
    Mol Imaging Biol; 2016 Feb; 18(1):127-34. PubMed ID: 26194010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promising potential of new generation translocator protein tracers providing enhanced contrast of arthritis imaging by positron emission tomography in a rat model of arthritis.
    Gent YY; Weijers K; Molthoff CF; Windhorst AD; Huisman MC; Kassiou M; Jansen G; Lammertsma AA; van der Laken CJ
    Arthritis Res Ther; 2014 Mar; 16(2):R70. PubMed ID: 24625077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Endothelial 18-kDa Translocator Protein on the Quantification of
    Wimberley C; Lavisse S; Brulon V; Peyronneau MA; Leroy C; Bodini B; Remy P; Stankoff B; Buvat I; Bottlaender M
    J Nucl Med; 2018 Feb; 59(2):307-314. PubMed ID: 28775204
    [No Abstract]   [Full Text] [Related]  

  • 26. Metabolism and quantification of [(18)F]DPA-714, a new TSPO positron emission tomography radioligand.
    Peyronneau MA; Saba W; Goutal S; Damont A; Dollé F; Kassiou M; Bottlaender M; Valette H
    Drug Metab Dispos; 2013 Jan; 41(1):122-31. PubMed ID: 23065531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New structure-activity relationships of N-acetamide substituted pyrazolopyrimidines as pharmacological ligands of TSPO.
    Li J; Schulte ML; Nickels ML; Manning HC
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3472-7. PubMed ID: 27353534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the novel TSPO radiotracer 2-(7-butyl-2-(4-(2-([
    Tang D; Fujinaga M; Hatori A; Zhang Y; Yamasaki T; Xie L; Mori W; Kumata K; Liu J; Manning HC; Huang G; Zhang MR
    Eur J Med Chem; 2018 Apr; 150():1-8. PubMed ID: 29505933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET imaging of neuroinflammation in a rat traumatic brain injury model with radiolabeled TSPO ligand DPA-714.
    Wang Y; Yue X; Kiesewetter DO; Niu G; Teng G; Chen X
    Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1440-9. PubMed ID: 24615467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parametric Binding Images of the TSPO Ligand 18F-DPA-714.
    Golla SS; Boellaard R; Oikonen V; Hoffmann A; van Berckel BN; Windhorst AD; Virta J; Te Beek ET; Groeneveld GJ; Haaparanta-Solin M; Luoto P; Savisto N; Solin O; Valencia R; Thiele A; Eriksson J; Schuit RC; Lammertsma AA; Rinne JO
    J Nucl Med; 2016 Oct; 57(10):1543-1547. PubMed ID: 27261521
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Kobayashi M; Jiang T; Telu S; Zoghbi SS; Gunn RN; Rabiner EA; Owen DR; Guo Q; Pike VW; Innis RB; Fujita M
    J Cereb Blood Flow Metab; 2018 Mar; 38(3):393-403. PubMed ID: 28322082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific imaging of inflammation with the 18 kDa translocator protein ligand DPA-714 in animal models of epilepsy and stroke.
    Harhausen D; Sudmann V; Khojasteh U; Müller J; Zille M; Graham K; Thiele A; Dyrks T; Dirnagl U; Wunder A
    PLoS One; 2013; 8(8):e69529. PubMed ID: 23936336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo evaluation of inflammatory bowel disease with the aid of μPET and the translocator protein 18 kDa radioligand [18F]DPA-714.
    Bernards N; Pottier G; Thézé B; Dollé F; Boisgard R
    Mol Imaging Biol; 2015 Feb; 17(1):67-75. PubMed ID: 25015387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide.
    Tang D; Hight MR; McKinley ET; Fu A; Buck JR; Smith RA; Tantawy MN; Peterson TE; Colvin DC; Ansari MS; Nickels M; Manning HC
    J Nucl Med; 2012 Feb; 53(2):287-94. PubMed ID: 22251555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation.
    Arlicot N; Vercouillie J; Ribeiro MJ; Tauber C; Venel Y; Baulieu JL; Maia S; Corcia P; Stabin MG; Reynolds A; Kassiou M; Guilloteau D
    Nucl Med Biol; 2012 May; 39(4):570-8. PubMed ID: 22172392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and testing of a p-H2 hyperpolarized 13C probe based on the pyrazolo[1,5-a]pyrimidineacetamide DPA-713, an MRI vector to target the peripheral benzodiazepine receptors.
    Cerutti E; Viale A; Damont A; Dollé F; Aime S
    Magn Reson Chem; 2011 Dec; 49(12):795-800. PubMed ID: 22095873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TSPO-PET and diffusion-weighted MRI for imaging a mouse model of infiltrative human glioma.
    Pigeon H; Pérès EA; Truillet C; Jego B; Boumezbeur F; Caillé F; Zinnhardt B; Jacobs AH; Le Bihan D; Winkeler A
    Neuro Oncol; 2019 Jun; 21(6):755-764. PubMed ID: 30721979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical imaging evaluation of novel TSPO-PET ligand 2-(5,7-Diethyl-2-(4-(2-[(18)F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([ (18)F]VUIIS1008) in glioma.
    Tang D; Nickels ML; Tantawy MN; Buck JR; Manning HC
    Mol Imaging Biol; 2014 Dec; 16(6):813-20. PubMed ID: 24845529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [
    Kim K; Kim H; Bae SH; Lee SY; Kim YH; Na J; Lee CH; Lee MS; Ko GB; Kim KY; Lee SH; Song IH; Cheon GJ; Kang KW; Kim SE; Chung JK; Kim EE; Paek SH; Lee JS; Lee BC; Youn H
    Theranostics; 2020; 10(20):9315-9331. PubMed ID: 32802194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of novel potent TSPO PET ligands with 2-phenylpyrazolo[1,5-a]pyrimidin-3-yl acetamide.
    Hieu Tran V; Park H; Park J; Kwon YD; Kang S; Ho Jung J; Chang KA; Chul Lee B; Lee SY; Kang S; Kim HK
    Bioorg Med Chem; 2019 Sep; 27(18):4069-4080. PubMed ID: 31353076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.